Failure to reach therapeutic levels of rifampicin and isoniazid by recommended dosages

Infect Dis (Lond). 2017 Jul;49(7):552-555. doi: 10.1080/23744235.2017.1292542. Epub 2017 Feb 19.

Authors

Affiliations

¹ a Research Laboratories , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
² b Department of Lab Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
³ c Department of Respiratory Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
⁴ d Department of Internal Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.

PMID: 28276803
DOI: 10.1080/23744235.2017.1292542

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Antitubercular Agents / administration & dosage*
Antitubercular Agents / blood
Antitubercular Agents / therapeutic use
Child
Humans
Isoniazid / administration & dosage*
Isoniazid / blood
Isoniazid / therapeutic use
Middle Aged
Rifampin / administration & dosage*
Rifampin / blood
Rifampin / therapeutic use
Treatment Outcome
Tuberculosis, Pulmonary / drug therapy
Young Adult

Substances

Antitubercular Agents
Isoniazid
Rifampin